Efficacy and safety of upadacitinib as an induction therapy for patients with moderately-to-severely active ulcerative colitis: combined results from 382 subjects in the phase 2b study U-ACHIEVE

Peter D.R. Higgins  1     Xavier Hebuterne  2     Jesse Siffledeen  3     Wen Zhou  4     Fabio Cataldi  4     Wangang Xie  4     Ana P. Lacerda  4     Silvio Danese  5    
1 University of Michigan,Ann Arbor,United States
2 Service de Gastro-Ent√©rologie et Nutrition Clinique, Universit√© de Nice-Sophia-Antipolis,Nice,France
3 University of Alberta,Edmonton,Canada
4 AbbVie Inc.,Chicago,United States
5 Istit

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing